Jeffrey E. Green

Transgenic Oncogenesis and Genomics Section, National Cancer Institute

Affiliated withNational Cancer Institute

Research Area

Biography

Jeffrey E. Green has not added Biography.
If you are Jeffrey E. Green and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 39	2011

Other Publications

Article	Year
Development of PIN and prostate adenocarcinoma cell lines: a model system for multistage tumor progression. Neoplasia (New York, N.Y.)\| PubMed ID: 11896566	2002
Ventral prostate predominant l, a novel mouse gene expressed exclusively in the prostate. The Prostate\| PubMed ID: 11920954	2002
Initiating oncogenic event determines gene-expression patterns of human breast cancer models. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 12011455	2002
Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice. Cancer research\| PubMed ID: 12124322	2002
Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin. International journal of cancer. Journal international du cancer\| PubMed ID: 12209972	2002
Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Cancer research\| PubMed ID: 12235003	2002
Validation of transgenic mammary cancer models: goals of the NCI Mouse Models of Human Cancer Consortium and the mammary cancer CD-ROM. Transgenic research\| PubMed ID: 12509138	2002
Development and characterization of a progressive series of mammary adenocarcinoma cell lines derived from the C3(1)/SV40 Large T-antigen transgenic mouse model. Breast cancer research and treatment\| PubMed ID: 12602905	2003
Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models. Carcinogenesis\| PubMed ID: 12663504	2003
Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis. Diagnostic molecular pathology : the American journal of surgical pathology, part B\| PubMed ID: 12766610	2003
The use of genetically altered mice for breast cancer prevention studies. The Journal of nutrition\| PubMed ID: 12840216	2003
Induction of cre recombinase activity using modified androgen receptor ligand binding domains: a sensitive assay for ligand-receptor interactions. Nucleic acids research\| PubMed ID: 12888538	2003
Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors. Cancer research\| PubMed ID: 12907608	2003
Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 14734487	2004
Genomic approaches to understanding mammary tumor progression in transgenic mice and responses to therapy. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 14734496	2004
Interrogating mouse mammary cancer models: insights from gene expression profiling. Journal of mammary gland biology and neoplasia\| PubMed ID: 14973376	2003
Application of gene expression profiling for validating models of human breast cancer. Toxicologic pathology\| PubMed ID: 15209407	2004
Effects of pooling mRNA in microarray class comparisons. Bioinformatics (Oxford, England)\| PubMed ID: 15247103	2004
Identification of a novel putative non-selenocysteine containing phospholipid hydroperoxide glutathione peroxidase (NPGPx) essential for alleviating oxidative stress generated from polyunsat... The Journal of biological chemistry\| PubMed ID: 15294905	2004
Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease. Cancer research\| PubMed ID: 15342376	2004
Gene expression profiling identifies a unique androgen-mediated inflammatory/immune signature and a PTEN (phosphatase and tensin homolog deleted on chromosome 10)-mediated apoptotic response... Molecular endocrinology (Baltimore, Md.)\| PubMed ID: 15358834	2004
Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer. Oncogene\| PubMed ID: 15378000	2004
Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms. Oncogene\| PubMed ID: 15592523	2005
Gene expression profiling identifies IL-13 receptor alpha 2 chain as a therapeutic target in prostate tumor cells overexpressing adrenomedullin. International journal of cancer. Journal international du cancer\| PubMed ID: 15609296	2005
Molecular mechanisms of breast cancer progression: lessons from mouse mammary cancer models and gene expression profiling. Breast disease\| PubMed ID: 15687699	2004
The promise of genetically engineered mice for cancer prevention studies. Nature reviews. Cancer\| PubMed ID: 15738982	2005
Prostate cancer and the genomic revolution: Advances using microarray analyses. Mutation research\| PubMed ID: 15950992	2005
Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse. Endocrinology\| PubMed ID: 16141391	2005
Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice. Genome biology\| PubMed ID: 16207355	2005
Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with Id-1 expression. Cancer research\| PubMed ID: 16585173	2006
Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling. Carcinogenesis\| PubMed ID: 16916863	2007
2-methoxyestradiol induces mammary gland differentiation through amphiregulin-epithelial growth factor receptor-mediated signaling: molecular distinctions from the mammary gland of pregnant ... Endocrinology\| PubMed ID: 17158205	2007
Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis. International journal of cancer. Journal international du cancer\| PubMed ID: 17278099	2007
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome biology\| PubMed ID: 17493263	2007
Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis. Cancer research\| PubMed ID: 17804718	2007
Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms. Cancer research\| PubMed ID: 17804756	2007
Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways. Cancer research\| PubMed ID: 17974970	2007
Comparing genetically engineered mouse mammary cancer models with human breast cancer by expression profiling. Breast disease\| PubMed ID: 18057542	2007
Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer research\| PubMed ID: 18559513	2008
Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer research\| PubMed ID: 18676848	2008
Unlocking the power of cross-species genomic analyses: identification of evolutionarily conserved breast cancer networks and validation of preclinical models. Breast cancer research : BCR\| PubMed ID: 18828875	2008
Human adrenomedullin up-regulates interleukin-13 receptor alpha2 chain in prostate cancer in vitro and in vivo: a novel approach to sensitize prostate cancer to anticancer therapy. Cancer research\| PubMed ID: 19010904	2008
VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop. Experimental cell research\| PubMed ID: 20006606	2010
Molecular characterization of the Ggamma-globin-Tag transgenic mouse model of hormone refractory prostate cancer: comparison to human prostate cancer. The Prostate\| PubMed ID: 20058236	2010
Genomic analyses as a guide to target identification and preclinical testing of mouse models of breast cancer. Toxicologic pathology\| PubMed ID: 20080934	2010
Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 20304630	2010
Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry. Journal of proteome research\| PubMed ID: 20557134	2010
Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer research\| PubMed ID: 20570886	2010
Modeling metastasis biology and therapy in real time in the mouse lung. The Journal of clinical investigation\| PubMed ID: 20644255	2010
Identifying functional miRNA-mRNA regulatory modules with correspondence latent dirichlet allocation. Bioinformatics (Oxford, England)\| PubMed ID: 20956247	2010
Multivariate analysis of a 3D mass spectral image for examining tissue heterogeneity. Integrative biology : quantitative biosciences from nano to macro\| PubMed ID: 21212877	2011
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. PloS one\| PubMed ID: 21364753	2011
BMI1 suffers a degrading experience. Cell cycle (Georgetown, Tex.)\| PubMed ID: 21593587	2011
Distinctions in gastric cancer gene expression signatures derived from laser capture microdissection versus histologic macrodissection. BMC medical genomics\| PubMed ID: 21635755	2011
Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage. Genome biology\| PubMed ID: 21846369	2011
MicroRNA regulation in cancer-associated fibroblasts. Cancer immunology, immunotherapy : CII\| PubMed ID: 22083346	2012
miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC medical genomics\| PubMed ID: 22112324	2011